Drug Pricing EO Reveals Plan To Build Off CGT Access Model in Medicaid

By Gabrielle Wanneh / April 16, 2025 at 8:17 PM

President Donald Trump’s plans to bring down prescription drug costs include building off a Biden-era CMS innovation center model to pay for expensive sickle-cell medications based on amounts that align with the actual value of the treatments in terms of efficacy and outcomes, the president’s executive order on lowering drug prices released Tuesday (April 15) alludes.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.